139 related articles for article (PubMed ID: 30106430)
1. Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.
Dong Q; Lv C; Zhang G; Yu Z; Kong C; Fu C; Zeng Y
Oncol Rep; 2018 Oct; 40(4):2307-2315. PubMed ID: 30106430
[TBL] [Abstract][Full Text] [Related]
2. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
3. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
[TBL] [Abstract][Full Text] [Related]
4. Global transcriptome‑wide analysis of the function of GDDR in acute gastric lesions.
Zhang Z; Zhu J; Dong Y; Xu H; Jiang T; Li W; Xu D; Shi L; Yu J; Zhang J; Du J
Mol Med Rep; 2017 Dec; 16(6):8673-8684. PubMed ID: 28990076
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
6. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
Chen Z; Hu H
Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
[TBL] [Abstract][Full Text] [Related]
8. An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes.
Thiemeyer H; Taher L; Schille JT; Packeiser EM; Harder LK; Hewicker-Trautwein M; Brenig B; Schütz E; Beck J; Nolte I; Murua Escobar H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768937
[TBL] [Abstract][Full Text] [Related]
9. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
10. Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data.
Cheng WS; Tao H; Hu EP; Liu S; Cai HR; Tao XL; Zhang L; Mao JJ; Yan DL
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3504-10. PubMed ID: 25491628
[TBL] [Abstract][Full Text] [Related]
11. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
[TBL] [Abstract][Full Text] [Related]
12. Investigation of key genes associated with prostate cancer using RNA-seq data.
Wu J; Feng F; Yang D; Yu S; Liu J; Gao Z
Int J Biol Markers; 2014 Mar; 29(1):e86-92. PubMed ID: 24366848
[TBL] [Abstract][Full Text] [Related]
13. Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
Kasajima R; Yamaguchi R; Shimizu E; Tamada Y; Niida A; Tremmel G; Kishida T; Aoki I; Imoto S; Miyano S; Uemura H; Miyagi Y
Oncol Rep; 2020 Mar; 43(3):943-952. PubMed ID: 32020225
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Zhang W; Liu S; Zhan H; Yan Z; Zhang G
Mol Med Rep; 2018 Oct; 18(4):3673-3682. PubMed ID: 30106143
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
[TBL] [Abstract][Full Text] [Related]
17. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
Wang R; Li J; Zhao Y; Li Y; Yin L
Breast Cancer; 2018 Mar; 25(2):206-212. PubMed ID: 29139094
[TBL] [Abstract][Full Text] [Related]
18. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
20. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
